Skip to main content

Abstract

Gout is caused by the crystal deposition of monosodium urate in and around joint tissues. The first joint affected in the majority of cases is the first metatarsophalangeal joint, a condition known as podagra. Acute gout is characterized by the rapid development of warmth, swelling, erythema, and pain in the affected joint. The natural history of gout is to worsen with time, progressing through the stages of asymptomatic hyperuri-cemia and acute intermittent gouty attacks to tophaceous gout. The time period between the first development of acute intermittent gouty attacks and the appearance of chronic tophaceous gout is approximately a decade in most cases. The development of tophaceous deposits of monosodium urate is a function of the degree and duration of hyperuricemia. However, most people with hyperuricemia never develop clinical gout.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, Nuki G. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005. Ann Rheum Dis. 2008;67:960–6

    Article  PubMed  CAS  Google Scholar 

  • Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, Streit J, Joseph-Ridge N. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med. 2005;353:2450–61

    Article  PubMed  CAS  Google Scholar 

  • Ben-Chetrit E, Levy M. Colchicine: 1998 update. Semin Arthritis Rheum. 1998;28(1):48–59

    Article  PubMed  CAS  Google Scholar 

  • Bomalaski JS, Lluberas GR, Schumacher HR Jr. Monosodium urate crystals in the knee joints of patients with asymptomatic nontopha-ceous gout. Arthritis Rheum. 1986;29(12):1480–4

    Article  PubMed  CAS  Google Scholar 

  • Centers for Disease Control and Prevention, national Center for Health Statistics. Vital and health statistics: current estimates from the national Health Interview Survey, 1996. Series 10, No. 200. Atlanta: Department of Health and Human Services (US). Available at http://www.cdc.gov/nchs/data/series/sr_10/sr10_200.pdf

  • Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol. 2008;9(2):71–92

    Article  PubMed  Google Scholar 

  • Choi MH, MacKenzie JD, Dalinka MK. Imaging features of crystal-induced arthropathy. Rheum Dis Clin N Am. 2006;32:427–46

    Article  Google Scholar 

  • Cronstein BN, Terkeltaub R. The inflammatory process of gout and its treatment. Arthritis Res Ther. 2006;8(Suppl 1):S3

    Article  PubMed  Google Scholar 

  • Edwards NL. The role of hyperuricemia and gout in kidney and cardiovascular disease. Cleve Clin J Med. 2008;75(Suppl 5):S13–6

    Article  PubMed  Google Scholar 

  • Famaey JP. Colchicine in therapy. State of the art and new perspectives for an old drug. Clin Exp Rheum. 1988;6(3):305–17

    CAS  Google Scholar 

  • Faraj AA, Omonbude OD, Godwin P. Gram staining in the diagnosis of acute septic arthritis. Acta orthop Belg. 2002;68(4):388–91

    PubMed  CAS  Google Scholar 

  • Hippocrates. The genuine works of Hippocrates, volumes 1 and 2. Translated and edited by Adams F. New York: Wood; 1886

    Google Scholar 

  • Molad Y, Cronstein BN, Malawista SE. Colchicine. In: Smyth CJ, Holers VM, editors. Gout, hyperuricemia, and other crystal-associated arthropathies. New York: Marcel Dekker; 1998. p. 193–204

    Google Scholar 

  • Pascual E, Batlle-Gualda E, Martinez A, Rosas J, Vela P. Synovial fluid analysis for diagnosis of intercritical gout. Ann Intern Med. 1999;131:756–9

    Article  PubMed  CAS  Google Scholar 

  • Shah K, Spear J, Nathanson LA, McCauley J, Edlow JA. J Emerg Med. 2007;32(1):23–26

    Article  PubMed  Google Scholar 

  • Urano W, Yamanaka H, Tsutani H, Nakajima H, Matsuda Y, Taniguchi A, Hara M, Kamatani N. The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis. J Rheumatol. 2002;29:1950–3

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Cronstein, B.N., Pillinger, M.H. (2009). The Clinical Features of Gout. In: Stone, J.H. (eds) A Clinician's Pearls and Myths in Rheumatology. Springer, London. https://doi.org/10.1007/978-1-84800-934-9_34

Download citation

  • DOI: https://doi.org/10.1007/978-1-84800-934-9_34

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84800-933-2

  • Online ISBN: 978-1-84800-934-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics